Logo image of INL.DE

INTEL CORP (INL.DE) Stock Fundamental Analysis

FRA:INL - Deutsche Boerse Ag - US4581401001 - Common Stock - Currency: EUR

17.951  -0.24 (-1.3%)

Fundamental Rating

2

Overall INL gets a fundamental rating of 2 out of 10. We evaluated INL against 52 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of INL have multiple concerns. INL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

INL had positive earnings in the past year.
INL had a positive operating cash flow in the past year.
Of the past 5 years INL 4 years were profitable.
INL had a positive operating cash flow in each of the past 5 years.
INL.DE Yearly Net Income VS EBIT VS OCF VS FCFINL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

1.2 Ratios

INL has a Return On Assets of -9.99%. This is amonst the worse of the industry: INL underperforms 86.54% of its industry peers.
INL's Return On Equity of -19.24% is on the low side compared to the rest of the industry. INL is outperformed by 86.54% of its industry peers.
Industry RankSector Rank
ROA -9.99%
ROE -19.24%
ROIC N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
INL.DE Yearly ROA, ROE, ROICINL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Gross Margin of INL (31.67%) is worse than 84.62% of its industry peers.
INL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for INL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
INL.DE Yearly Profit, Operating, Gross MarginsINL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

INL does not have a ROIC to compare to the WACC, probably because it is not profitable.
INL has more shares outstanding than it did 1 year ago.
INL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, INL has an improved debt to assets ratio.
INL.DE Yearly Shares OutstandingINL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
INL.DE Yearly Total Debt VS Total AssetsINL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that INL is in the distress zone and has some risk of bankruptcy.
INL's Altman-Z score of 1.20 is on the low side compared to the rest of the industry. INL is outperformed by 82.69% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that INL is not too dependend on debt financing.
The Debt to Equity ratio of INL (0.45) is worse than 71.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC7.93%
INL.DE Yearly LT Debt VS Equity VS FCFINL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.31 indicates that INL should not have too much problems paying its short term obligations.
INL has a worse Current ratio (1.31) than 82.69% of its industry peers.
INL has a Quick Ratio of 1.31. This is a bad value and indicates that INL is not financially healthy enough and could expect problems in meeting its short term obligations.
INL has a worse Quick ratio (0.93) than 78.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.93
INL.DE Yearly Current Assets VS Current LiabilitesINL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for INL have decreased strongly by -64.29% in the last year.
INL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -36.62% yearly.
INL shows a decrease in Revenue. In the last year, the revenue decreased by -3.97%.
INL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.90% yearly.
EPS 1Y (TTM)-64.29%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-27.78%
Revenue 1Y (TTM)-3.97%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-0.45%

3.2 Future

The Earnings Per Share is expected to grow by 47.57% on average over the next years. This is a very strong growth
Based on estimates for the next years, INL will show a small growth in Revenue. The Revenue will grow by 1.95% on average per year.
EPS Next Y-1.62%
EPS Next 2Y51.12%
EPS Next 3Y48.53%
EPS Next 5Y47.57%
Revenue Next Year1%
Revenue Next 2Y3.68%
Revenue Next 3Y3.7%
Revenue Next 5Y1.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INL.DE Yearly Revenue VS EstimatesINL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
INL.DE Yearly EPS VS EstimatesINL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4 5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

INL is valuated quite expensively with a Price/Earnings ratio of 44.88.
80.77% of the companies in the same industry are cheaper than INL, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of INL to the average of the S&P500 Index (28.18), we can say INL is valued expensively.
With a Price/Forward Earnings ratio of 17.83, INL is valued on the expensive side.
INL's Price/Forward Earnings ratio is in line with the industry average.
INL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 44.88
Fwd PE 17.83
INL.DE Price Earnings VS Forward Price EarningsINL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.52
INL.DE Per share dataINL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

INL's earnings are expected to grow with 48.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.12%
EPS Next 3Y48.53%

More info and screens

0

5. Dividend

5.1 Amount

INL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTEL CORP

FRA:INL (5/5/2025, 2:33:08 PM)

17.951

-0.24 (-1.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners66.64%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap78.30B
Analysts56.86
Price Target19.77 (10.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)-21.66%
DP-5.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1129.32%
Min EPS beat(2)2.81%
Max EPS beat(2)2255.84%
EPS beat(4)3
Avg EPS beat(4)771.99%
Min EPS beat(4)-80.55%
Max EPS beat(4)2255.84%
EPS beat(8)7
Avg EPS beat(8)461.8%
EPS beat(12)9
Avg EPS beat(12)311.32%
EPS beat(16)13
Avg EPS beat(16)239.34%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)1.03%
Max Revenue beat(2)1.23%
Revenue beat(4)3
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-2.8%
Max Revenue beat(4)1.23%
Revenue beat(8)5
Avg Revenue beat(8)0.48%
Revenue beat(12)6
Avg Revenue beat(12)-1.2%
Revenue beat(16)9
Avg Revenue beat(16)0.31%
PT rev (1m)-12.54%
PT rev (3m)-18.01%
EPS NQ rev (1m)-73.96%
EPS NQ rev (3m)-90.99%
EPS NY rev (1m)-2.38%
EPS NY rev (3m)-48.91%
Revenue NQ rev (1m)-7.18%
Revenue NQ rev (3m)-10.7%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-4.47%
Valuation
Industry RankSector Rank
PE 44.88
Fwd PE 17.83
P/S 1.67
P/FCF N/A
P/OCF 8.6
P/B 0.89
P/tB 1.24
EV/EBITDA 14.52
EPS(TTM)0.4
EY2.23%
EPS(NY)1.01
Fwd EY5.61%
FCF(TTM)-2.59
FCFYN/A
OCF(TTM)2.09
OCFY11.62%
SpS10.72
BVpS20.16
TBVpS14.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.99%
ROE -19.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 6.09
Cap/Depr 201.33%
Cap/Sales 43.66%
Interest Coverage N/A
Cash Conversion 140.08%
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.93
Altman-Z 1.2
F-Score3
WACC7.93%
ROIC/WACCN/A
Cap/Depr(3y)223.59%
Cap/Depr(5y)192.25%
Cap/Sales(3y)44.1%
Cap/Sales(5y)35.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.29%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-27.78%
EPS Next Y-1.62%
EPS Next 2Y51.12%
EPS Next 3Y48.53%
EPS Next 5Y47.57%
Revenue 1Y (TTM)-3.97%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-0.45%
Revenue Next Year1%
Revenue Next 2Y3.68%
Revenue Next 3Y3.7%
Revenue Next 5Y1.95%
EBIT growth 1Y-678.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1368.53%
EBIT Next 3Y187.89%
EBIT Next 5Y96.64%
FCF growth 1Y35.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.09%
OCF growth 3Y-34.47%
OCF growth 5Y-24.21%